Segundo González - Concepedia

Author

Segundo González

Also Known As

González S, S GONZALEZ, S Gonzalez, S González, S. Gonzalez, S. Gonzalez-Rodriguez, S. González, S.G. Rodriguez, Sara González-Rodríguez, Segundo Gonzalez

184

Publications

6.9K

Citations

H-Index

118

Concepts

All Affiliations

Universidad de Oviedo Hospital Universitario Central de Asturias Instituto de Investigación Sanitaria del Principado de Asturias Hospital Universitario De Cabueñes Hospital de Santo Espirito de Angra do Heroísmo

About

Segundo González is an author at Universidad de Oviedo specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	35	2.1K
2	Engineering	3	3	96
3	Natural Sciences	3	3	109
4	Health Sciences	2	2	146
5	Public Health	2	2	106

Segundo González

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands Brett K. Kaiser, Daesong Yim, I‐Ting Chow, Nature MedicineImmunologyDisulphide-isomerase-enabled SheddingImmunotherapyCancer Biology	2007	372
HLA‐B27 polymorphism and worldwide susceptibility to ankylosing spondylitis Severino González-Roces, Victoria Álvarez, Segundo González, Tissue Antigens	1997	214
The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis Segundo González, Jesús Martı́nez-Borra, Juan Carlos Torre‐Alonso, Arthritis & Rheumatism	1999	147
Protective Effect of the HLA‐Bw4I80 Epitope and the Killer Cell Immunoglobulin‐Like Receptor 3DS1 Gene against the Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection Antonio López‐Vázquez, Jesús Martı́nez-Borra, Ramón Pérez, The Journal of Infectious Diseases HistocompatibilityImmunologyPathologyImmunotherapyHcv Carriers	2005	122
HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer Alejandro López‐Soto, Alicia R. Folgueras, Edward Seto, Oncogene Tumor BiologyCancer ImmunosurveillancePotential ImplicationsImmunologyTumor Immunity	2009	117
High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease Jesús Martı́nez-Borra, Carlos López‐Larrea, Segundo González, The American Journal of Gastroenterology	2002	110
Epithelial–Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor Alejandro López‐Soto, Leticía Huergo-Zapico, José Alberto Galván, The Journal of Immunology Epithelial–mesenchymal Transition InducesImmunologyImmune RegulationNk CellsImmunologic Mechanism	2013	110
Tnf-α− 308A Promoter Polymorphism Is Associated With Enhanced Tnf-α Production and Inflammatory Activity in Crohn's Patients With Fistulizing Disease Segundo González, Jesús Martı́nez-Borra, Antonio López‐Vázquez, The American Journal of Gastroenterology	2003	109
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia Christian Sordo‐Bahamonde, Seila Lorenzo‐Herrero, Ana Pilar González, Cancers Chronic Lymphocytic LeukemiaImmunologyNk CellsImmunotherapyImmune Checkpoint	2021	99
17β-Estradiol Activates Glucose Uptake via GLUT4 Translocation and PI3K/Akt Signaling Pathway in MCF-7 Cells Pablo Garrido, Javier Morán, Ana Alonso, Endocrinology	2013	93

Page 1